Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Insider Filings - BAFFI ROBERT
Last Updated 
20-May-13
Enter symbol:
symbol lookup
 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

BAFFI ROBERT: Declared Holdings
Company/RelationshipReportedShares  Ownership
BioMarin Pharmaceutical Inc.
Officer
NasdaqGS:BMRN
(historical quotes, profile, SEC, other insiders) 		15-May-13
1-May-13		62,262
   9,043
71,305		  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
15-May-13 12,000BMRN Acquisition (Non Open Market) at $0 per share.
14-May-13 20,000BMRN Automatic Sale at $70 per share.
(Proceeds of $1,400,000)
14-May-13 20,000BMRN Option Exercise at $21.51 per share.
(Cost of $430,200)
8-May-13 2,088BMRN Disposition (Non Open Market) at $65.32 per share.
(Value of $136,388)
3-May-13 20,000BMRN Automatic Sale at $67 per share.
(Proceeds of $1,340,000)
3-May-13 20,000BMRN Option Exercise at $14.39 per share.
(Cost of $287,800)
1-May-13 *805BMRN Acquisition (Non Open Market) at $0 per share.
1-May-13 805BMRN Disposition (Non Open Market) at $0 per share.
30-Apr-13 805BMRN Acquisition (Non Open Market) at $23.21 per share.
(Value of $18,684)
10-Apr-13 20,000BMRN Automatic Sale at $64 per share.
(Proceeds of $1,280,000)
10-Apr-13 20,000BMRN Option Exercise at $14.39 per share.
(Cost of $287,800)
18-Mar-13 20,000BMRN Automatic Sale at $61.02 per share.
(Proceeds of $1,220,400)
18-Mar-13 20,000BMRN Option Exercise at $14.39 per share.
(Cost of $287,800)
22-Jan-13 2,675BMRN Disposition (Non Open Market) at $0 per share.
22-Jan-13 19,575BMRN Automatic Sale at $55 per share.
(Proceeds of $1,076,625)
22-Jan-13 *2,675BMRN Acquisition (Non Open Market) at $0 per share.
22-Jan-13 19,575BMRN Option Exercise at $17.54 per share.
(Cost of $343,345)
3-Jan-13 20,000BMRN Option Exercise at $17.54 per share.
(Cost of $350,800)
3-Jan-13 20,000BMRN Automatic Sale at $53 per share.
(Proceeds of $1,060,000)
15-Nov-12 20,000BMRN Option Exercise at $17.54 per share.
(Cost of $350,800)
15-Nov-12 20,000BMRN Automatic Sale at $51 per share.
(Proceeds of $1,020,000)
5-Nov-12 60,000BMRN Automatic Sale at $46 - $49 per share.
(Proceeds of about $2,850,000)
5-Nov-12 60,000BMRN Option Exercise at $17.33 - $17.54 per share.
(Cost of about $1,046,000)
2-Nov-12 161BMRN Disposition (Non Open Market) at $0 per share.
2-Nov-12 *161BMRN Acquisition (Non Open Market) at $0 per share.
16-Oct-12 20,000BMRN Automatic Sale at $43 per share.
(Proceeds of $860,000)
16-Oct-12 20,000BMRN Option Exercise at $17.33 per share.
(Cost of $346,599)
8-May-12 16,000BMRN Acquisition (Non Open Market)
1-May-12 920BMRN Disposition (Non Open Market) at $0 per share.
1-May-12 *920BMRN Acquisition (Non Open Market) at $0 per share.
30-Apr-12 920BMRN Acquisition (Non Open Market) at $19.35 per share.
(Value of $17,802)
24-Feb-12 91,313BMRN Option Exercise at $6.13 - $11.74 per share.
24-Feb-12 91,313BMRN Sale at $34.84 per share.
(Proceeds of $3,181,344)
14-Nov-11 333BMRN Disposition (Non Open Market) at $0 per share.
14-Nov-11 *333BMRN Acquisition (Non Open Market) at $0 per share.
2-Aug-11 18,687BMRN Sale at $30.55 per share.
(Proceeds of $570,887)
2-Aug-11 18,687BMRN Option Exercise at $6.13 per share.
(Cost of $114,551)
7-Jun-11 2,000BMRN Option Exercise at $0 per share.
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?